Previous Close | 0.0800 |
Open | 0.0800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0800 - 0.0800 |
52 Week Range | 0.0800 - 0.0800 |
Volume | |
Avg. Volume | 0 |
Market Cap | 199.95M |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Feb 16, 2024 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for IMPZY
BORDEAUX, France & BOSTON, March 06, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, today announced its 2023 full-year results, as of December 31, 2023, as approved by the Board of Directors on March 5, 2024.
BORDEAUX, France & BOSTON, February 02, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), (the "Company"), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, announces the success of the capital increase in cash with preferential subscription rights for shareholders announced on January 4, 2024 (the "Capital Increase"). This operation raised €5.5 mill
BORDEAUX, France & BOSTON, January 25, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, announced the appointment of Max W. Painter as VP & General Manager of Implanet America. In this position, he will lead Implanet America, with the aim of optimizing its organizational structure to accelerate the